Form 4 for DRIO DarioHealth Corp.
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0001104659-24-091264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-20 | 2024-08-16+ | DRIO | Raphael Erez | CEO, Dir | P - Purchase | $0.898 | +10.0K | 1.92M | +0.5% | +$8,980 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | P | A | 2,000 | $0.89 | 1,914,059 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-16 | P | A | 3,000 | $0.9 | 1,917,059 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-19 | P | A | 5,000 | $0.9 | 1,922,059 | D | — | — |